Shenzhen Bioeasy Biotechnology Co. Ltd.

SHE:300942 China Biotechnology
Market Cap
$524.47 Million
CN¥3.85 Billion CNY
Market Cap Rank
#14600 Global
#3862 in China
Share Price
CN¥9.50
Change (1 day)
+2.15%
52-Week Range
CN¥7.34 - CN¥13.82
All Time High
CN¥40.28
About

Shenzhen Bioeasy Biotechnology Co., Ltd., together with its subsidiaries, provides rapid food testing reagents and instruments in China and internationally. The company offers test kits, including veterinary, melamine, mycotoxin, pesticide, adulteration, ATP, vitamin, and others; equipment, such as incubator, reader, suitcase lab, automatic pressers, and others; and materials comprising pretreatm… Read more

Shenzhen Bioeasy Biotechnology Co. Ltd. - Asset Resilience Ratio

Latest as of September 2025: 9.79%

Shenzhen Bioeasy Biotechnology Co. Ltd. (300942) has an Asset Resilience Ratio of 9.79% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets
CN¥145.05 Million
Cash + Short-term Investments
Total Assets
CN¥1.48 Billion
All company assets
Resilience Assessment
Low
Financial Resilience Level

Asset Resilience Ratio Trend (2019–2024)

This chart shows how Shenzhen Bioeasy Biotechnology Co. Ltd.'s Asset Resilience Ratio has changed over time. Compare with other companies' asset resilience ratios.

Liquid Assets Composition Over Time

This chart breaks down Shenzhen Bioeasy Biotechnology Co. Ltd.'s liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents CN¥0.00 0%
Short-term Investments CN¥145.05 Million 9.79%
Total Liquid Assets CN¥145.05 Million 9.79%

Asset Resilience Insights

  • Limited Liquidity: Shenzhen Bioeasy Biotechnology Co. Ltd. maintains only 9.79% of assets in liquid form.
  • This low level may indicate efficient asset utilization but could pose risks during economic downturns.
  • The company has significant short-term investments, indicating active treasury management.

Shenzhen Bioeasy Biotechnology Co. Ltd. Industry Peers by Asset Resilience Ratio

Compare Shenzhen Bioeasy Biotechnology Co. Ltd.'s asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Halozyme Therapeutics Inc
NASDAQ:HALO
Biotechnology 12.71%
Biomarin Pharmaceutical Inc
NASDAQ:BMRN
Biotechnology 3.28%
ESSA Pharma Inc
NASDAQ:EPIX
Biotechnology 21.42%
Shenzhen CAU Technology Co Ltd
SHE:000004
Biotechnology 6.20%
Pacific Shuanglin Bio pharmacy Co Ltd
SHE:000403
Biotechnology 6.88%
Nanhua Bio Medicine Co Ltd
SHE:000504
Biotechnology 11.93%
Jiangsu Sihuan Bioengineering Co Ltd
SHE:000518
Biotechnology 0.03%
Chengzhi Shareholding Co Ltd
SHE:000990
Biotechnology 6.73%

Annual Asset Resilience Ratio for Shenzhen Bioeasy Biotechnology Co. Ltd. (2019–2024)

The table below shows the annual Asset Resilience Ratio data for Shenzhen Bioeasy Biotechnology Co. Ltd..

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2024-12-31 20.79% CN¥302.92 Million CN¥1.46 Billion +11.94pp
2023-12-31 8.85% CN¥120.03 Million CN¥1.36 Billion -20.67pp
2021-12-31 29.52% CN¥340.21 Million CN¥1.15 Billion +26.29pp
2019-12-31 3.23% CN¥20.00 Million CN¥619.67 Million --
pp = percentage points